Issued Patents All Time
Showing 26–37 of 37 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10308717 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Laura Alexandra Johnson, Carl H. June, Andreas Loew, Marcela Maus, John Scholler +1 more | 2019-06-04 |
| 10287354 | Regulatable chimeric antigen receptor | Boris Engels, David Glass, Brian Granda, John Hastewell, Andreas Loew +9 more | 2019-05-14 |
| 10253086 | CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell | Hans Bitter, Jennifer Bordeaux, Barbara Brannetti, Naveen Dakappagari, Saar Gill +12 more | 2019-04-09 |
| 10221245 | Treatment of cancer using humanized anti-CD19 chimeric antigen receptor | Carl H. June, Andreas Loew, Marcela Maus, John Scholler | 2019-03-05 |
| 10174095 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Eugene Choi, Hilmar Erhard Ebersbach, David Glass, Heather Huet, Carl H. June +9 more | 2019-01-08 |
| 9988455 | Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies | Kurt Alex HELDWEIN, William Dole, John Trauger, Yuting Tang, Julia Neugebauer +1 more | 2018-06-05 |
| 9982046 | Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies | Kurt Alex HELDWEIN, Igor Splawski, Joshua Goldstein, William Dole, John Trauger +1 more | 2018-05-29 |
| 9815901 | Treatment of cancer using a CD123 chimeric antigen receptor | Saar Gill, David Glass, Saad Kenderian, Andreas Loew, Joan Mannick +7 more | 2017-11-14 |
| 9573988 | Effective targeting of primary human leukemia using anti-CD123 chimeric antigen receptor engineered T cells | Saar Gill, Carl H. June, Michael D. Kalos, Andreas Loew, John Scholler | 2017-02-21 |
| 9562101 | Lectin-like oxidized LDL receptor 1 antibodies and methods of use | Kurt Alex HELDWEIN, William Dole, John Trauger, Yuting Tang, Julia Neugebauer +1 more | 2017-02-07 |
| 9512222 | Lectin-like oxidized LDL receptor 1 antibodies and methods of use | Kurt Alex HELDWEIN, Igor Splawski, Joshua Goldstein, William Dole, John Trauger +1 more | 2016-12-06 |
| 9394368 | Treatment of cancer using humanized anti-EGFRvIII chimeric antigen receptor | Laura Alexandra Johnson, Carl H. June, Andreas Loew, Marcela Maus, John Scholler +1 more | 2016-07-19 |